About bremelanotide
Melanocortin receptor agonist
Used for
- Treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women
Usual adult dose
Inject 1.75 mg under the skin at least 45 minutes before anticipated sexual activity; maximum one dose in 24 hours and eight doses monthly.
Common side effects
- Nausea
- Flushing
- Headache
- Injection-site reactions
Important warnings
- May temporarily raise blood pressure and lower heart rate; avoid with uncontrolled hypertension or known cardiovascular disease.
- Can cause focal skin darkening, especially on the face, breasts, or gums; changes may persist after stopping.
- May delay stomach emptying and affect absorption of oral medicines.
- Not indicated for postmenopausal women or men, or to improve sexual performance.
Pregnancy
Not recommended; discontinue if pregnancy occurs. May reduce effectiveness of oral contraceptives.
Breastfeeding
There are no adequate data on presence in human milk or effects on the infant; use caution.
Interactions
- May slow absorption of oral medicines, including oral contraceptives and naltrexone.
- Avoid with other medicines that lower heart rate, such as oral beta blockers.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.